alternatives to glp-1 agonists New research from @doctorsigh shows that stopping medications doesn't have mean losing progress. The study compared three next-step strategies after discontinuing treatment: lifestyle changes, switching medications, or endoscopic gastric GLP-1 Receptor Agonists | New
Description
Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus a systematic review and meta-analysis of randomized control trials
They are not interchangeable with those products from a regulatory standpoint
The important signalling role of these hormones in the brain for obesity and type 2 obesity had been first flagged up following the discovery of leptin and later ghrelin
January 2, 2026: Trulicity (Dulaglutide) May Be Safe for Use by Pregnant Women, Study Suggests Trulicity (dulaglutide) is used by many patients to control their diabetes
Diabetes and kidney disease: role of oxidative stress
